D-0974-2017 Class III Terminated
FDA drug recall D-0974-2017 was initiated by Lupin Pharmaceuticals Inc. on Jun 22, 2017 and is designated Class III. Reason for recall: Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study. The recall status is terminated (terminated Jan 17, 2019). Affected quantity: 12480 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 19, 2017
- Initiation Date
- Jun 22, 2017
- Termination Date
- Jan 17, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12480 bottles
Product description
Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC: 68180-647-06
Reason for recall
Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.
Distribution pattern
Nationwide in the USA
Code information
Lots: H605712, H605711, H605710, EXP November 2018; H702255, H702202 EXP March 2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0974-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026